CDKN2A and neoplasm: As previously shown in a separate analysis of 46/62 NSCCUP-P with tumor and blood samples available (cohort 2), we analyzed HPV DNA, HPV E6*I mRNA and p16INK4A as well as antibodies to HPV proteins in sera (19).